BRIEF published on 06/10/2026 at 07:35, 1 month 14 days ago Sensorion Advances SENS-601 for GJB2-Related Hearing Loss Clinical Trials Gene Therapy Sensorion SENS-601 GJB2 Hearing Loss
BRIEF published on 06/10/2026 at 07:35, 1 month 14 days ago Sensorion Refocuses on SENS-601 for Gene Therapy Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
PRESS RELEASE published on 06/10/2026 at 07:30, 1 month 14 days ago Inside Information / Other news releases Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 Clinical Trials Gene Therapy Sensorion Regulatory Milestones GJB2-related Hearing Loss
BRIEF published on 05/18/2026 at 07:35, 2 months 6 days ago Fred Chereau appointed Managing Director of Sensorion Gene Therapy General Management Hearing Loss Sensory Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 2 months 6 days ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 2 months 6 days ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 2 months 11 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
PRESS RELEASE published on 05/13/2026 at 07:30, 2 months 11 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
BRIEF published on 05/05/2026 at 07:35, 2 months 19 days ago Sensorion is participating in the ASGCT annual conference Gene Therapy Hearing Loss SENS-601 Sensory ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 2 months 19 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
Published on 07/24/2026 at 09:10, 35 minutes ago HM Exploration Commences Optical & Acoustic Televiewer Program at the Lewis Pilley's Project
Published on 07/24/2026 at 08:00, 1 hour 45 minutes ago Galantas Announces Amendment to a Dragones Share Purchase Agreement
Published on 07/24/2026 at 05:55, 3 hours 50 minutes ago Alphinat Announces a Loss of $(44,521) for Quarter Ended May 31, 2026
Published on 07/24/2026 at 01:00, 8 hours 45 minutes ago Global Education Communities Corp. Named One of the Top 50 Profitable Companies in B.C. by Business In Vancouver
Published on 07/24/2026 at 00:00, 9 hours 45 minutes ago CoTec to Host July 2026 Business Update Webinar
Published on 07/24/2026 at 09:25, 19 minutes ago Two Peking University alumni awarded Fields Medals, 14 PKUers speak at the 2026 ICM
Published on 07/24/2026 at 09:00, 44 minutes ago Municipality Finance issues EUR 25 million notes under its MTN programme
Published on 07/24/2026 at 08:05, 1 hour 39 minutes ago TeamViewer Named Best-in-Class in PAC Innovation RADAR for Connected Worker Platforms, Three Years Running
Published on 07/24/2026 at 08:00, 1 hour 45 minutes ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
Published on 07/23/2026 at 17:45, 16 hours ago Air Liquide invests over 150M USD in the U.S. to facilitate the growth of a leading global memory chip manufacturer
Published on 07/23/2026 at 17:45, 16 hours ago Cegedim: Like-for-like revenue growth of 0.8% in the first half
